Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Current Gene Therapy is Scopus-indexed (Q1, CiteScore 6.7), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Bentham Science Publishers.
Checked against the index lists dated .
ISSN 1566-5232Verify ISSN ↗1875-5631Verify ISSN ↗
Publisher: Bentham Science Publishers
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Genetics (clinical) | 24 / 100 | 76th | Q1 |
| Genetics | 93 / 357 | 74th | Q2 |
| Drug Discovery | 49 / 161 | 69th | Q2 |
| Molecular Biology | 157 / 414 | 62nd | Q2 |
| Molecular Medicine | 69 / 179 | 61st | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2001–present, best quartile Q1, CiteScore 6.7.
Current Gene Therapy is Q1 in Genetics (clinical) (rank 24 of 100), Q2 in Genetics (rank 93 of 357) and Q2 in Drug Discovery (rank 49 of 161), by CiteScore 2025. It is ranked in 5 subject areas in all.
Current Gene Therapy is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 6.7, which places it in quartile Q1 at the 76th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.706, quartile Q2, with an H-index of 85.
Current Gene Therapy is published by Bentham Science Publishers. Its print ISSN is 1566-5232 and its online ISSN is 1875-5631.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Current Gene Therapy has an h-index of 90 and a 2-year mean of 3.97 citations per paper (OpenAlex). Its Scopus CiteScore is 6.7, quartile Q1. On 2-year citations it ranks #16 of 99 Scopus journals in Genetics (clinical).
Current Gene Therapy published 72 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2025–2026), authors are most often from China (41.1%), India (34.2%) and United States (4.4%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 1 retracted paper is recorded (0.8 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.